Zinc-alginate microparticles for controlled pulmonary delivery of proteins prepared by spray-drying

被引:47
作者
Moebus, Katrin [1 ]
Siepmann, Juergen [2 ]
Bodmeier, Roland [1 ]
机构
[1] Free Univ Berlin, Coll Pharm, D-12169 Berlin, Germany
[2] Univ Lille, Coll Pharm, INSERM U 1008, Lille, France
关键词
Alginate; Controlled release; Microencapsulation; Microparticles; Protein; Pulmonary delivery; LARGE POROUS PARTICLES; HUMAN GROWTH-HORMONE; CONTROLLED-RELEASE; DRUG-DELIVERY; MICROSPHERES; FORMULATION; SIZE; ENCAPSULATION; PHAGOCYTOSIS; INSTABILITY;
D O I
10.1016/j.ejpb.2012.01.018
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this study was to prepare novel Zn2+-cross-linked alginate microparticles for controlled pulmonary delivery of protein drugs via a simple one-step spray-drying process and to physicochemically characterize these systems. Microparticles were prepared by spray-drying aqueous alginate solutions, containing the model protein BSA, Zn(NH3)(4)SO4, and optionally additional excipients. Upon ammonia evaporation, the alginate was cross-linked by Zn2+-ions. The microparticles were characterized by SEM, laser and X-ray diffraction, gel electrophoresis, aerodynamic particle size, and drug release measurements. Particles in a size range suitable for deep lung administration were obtained. Pure alginate microparticles were spherical in shape, whereas the addition of zinc led to a more collapsed geometry. Protein release depended on the (i) alginate:ZnSO4 ratio (minimum release rate at 2:1); (ii) BSA content (decreasing release rate and extent with decreasing BSA content); (iii) type of release medium (increasing release rate with increasing phosphate concentration). The emitted microparticle dose was high for all formulations (similar to 90%). Fine particle fractions (FPF, depositing in the deep lung) up to 40% could be achieved. The FPF was affected by the BSA content, alginate:ZnSO4 ratio and presence/absence of poloxamer. Thus, novel Zn2+-cross-linked alginate microparticles were prepared via a simple one-step process, providing an interesting potential for controlled pulmonary delivery of proteins. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:121 / 130
页数:10
相关论文
共 43 条
  • [1] PULMONARY DELIVERY OF THERAPEUTIC PEPTIDES AND PROTEINS
    ADJEI, A
    GUPTA, P
    [J]. JOURNAL OF CONTROLLED RELEASE, 1994, 29 (03) : 361 - 373
  • [2] Adjei AL., 1997, INHALATION DELIVERY
  • [3] Chitosan-based delivery systems for protein therapeutics and antigens
    Amidi, Maryam
    Mastrobattista, Enrico
    Jiskoot, Wim
    Hennink, Wim E.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2010, 62 (01) : 59 - 82
  • [4] In situ gelling, bioadhesive nasal inserts for extended drug delivery: In vitro characterization of a new nasal dosage form
    Bertram, U
    Bodmeier, R
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 27 (01) : 62 - 71
  • [5] Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance
    Bosquillon, C
    Lombry, C
    Préat, V
    Vanbever, R
    [J]. JOURNAL OF CONTROLLED RELEASE, 2001, 70 (03) : 329 - 339
  • [6] How much particle surface corrugation is sufficient to improve aerosol performance of powders?
    Chew, NYK
    Tang, P
    Chan, HK
    Raper, JA
    [J]. PHARMACEUTICAL RESEARCH, 2005, 22 (01) : 148 - 152
  • [7] Use of solid corrugated particles to enhance powder aerosol performance
    Chew, NYK
    Chan, HK
    [J]. PHARMACEUTICAL RESEARCH, 2001, 18 (11) : 1570 - 1577
  • [8] Novel sustained release microspheres for pulmonary drug delivery
    Cook, RO
    Pannu, RK
    Kellaway, IW
    [J]. JOURNAL OF CONTROLLED RELEASE, 2005, 104 (01) : 79 - 90
  • [9] Chitosan-alginate microparticles as a protein carrier
    Coppi, G
    Iannuccelli, V
    Leo, E
    Bernabei, MT
    Cameroni, R
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2001, 27 (05) : 393 - 400
  • [10] Protein spray-freeze drying.: Effect of atomization conditions on particle size and stability
    Costantino, HR
    Firouzabadian, L
    Hogeland, K
    Wu, CC
    Beganski, C
    Carrasquillo, KG
    Córdova, M
    Griebenow, K
    Zale, SE
    Tracy, MA
    [J]. PHARMACEUTICAL RESEARCH, 2000, 17 (11) : 1374 - 1383